Cryoport Introduces The Cryoport Express Cryogenic HV3 Shipping System

(RTTNews) - Cryoport, Inc. (CYRX), a Tennessee-based provider of integrated temperature-controlled supply chain solutions Tuesday introduced the Cryoport Express Cryogenic HV3 Shipping System, its latest innovation in temperature-controlled supply chain offerings.

The HV3 offers exceptional protection and accessibility for biologics and temperature-sensitive materials. Its rectilinear design removes the need for palletization, allowing transport on narrow-bodied aircraft while meeting regional carrier requirements and minimizing delays. This innovation expands shipping options, improves patient access, and helps deliver life-saving therapies to underserved areas.

The HV3 shipping system enhances payload protection, offers space for accessories, and improves storage efficiency with stackable, nestable design. It complies with airline requirements, features integrated condition monitoring, and ensures superior temperature control at -150°C or lower, meeting the needs of advanced therapies with extended stability and security.

The HV3 features wheels and a front-facing handle for improved mobility and accessibility at point-of-care sites. Its scalable design enhances storage efficiency at manufacturing and clinical locations, reducing the need for additional resources. Compatible with Cryoport's Safepak System, it minimizes vibration and shock during the transport of cell and gene therapies.

The Cryoport Express Cryogenic HV3 Shipping System will be showcased at Phacilitate's Advanced Therapies Week on booth 141 and featured in a panel on patient-centric supply chain advancements on January 22, in Dallas, Texas, from 11 a.m. to 12 p.m. CST.

CYRX is currently trading at $7.94 or 5.87% on the Nasdaq Capital Market.